DNASE1L3 and sarcoma: Deng et al. (Deng et al., 2021) investigated the expression levels of DNASE1L3, and the results revealed the DNASE1L3 was a prognostic biomarker in cancer of the breast, kidney, liver, stomach, lung adenocarcinoma, and sarcoma via bioinformatics analysis using TCGA database.